These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10367949)

  • 1. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.
    Wiström J; Ahlm C; Lundberg S; Settergren B; Tärnvik A
    Vaccine; 1999 Apr; 17(17):2162-5. PubMed ID: 10367949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine.
    Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O
    Infection; 1995; 23(1):42-5. PubMed ID: 7744490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
    Das K; Gupta RK; Kumar V; Kar P
    World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
    Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; Murphy D; De Wals P; Ouakki M; Trudeau G; Massé R; Dionne M
    Vaccine; 2013 Jan; 31(3):448-51. PubMed ID: 23206974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.
    Cassidy WM; Watson B; Ioli VA; Williams K; Bird S; West DJ
    Pediatrics; 2001 Apr; 107(4):626-31. PubMed ID: 11335734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response following hepatitis B vaccine booster dose in children with and without prior immunization.
    Chongsrisawat V; Theamboonlers A; Khwanjaipanich S; Owatanapanich S; Sinlaparatsamee S; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):623-6. PubMed ID: 11414401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Salama II; Sami SM; Salama SI; Rabah TM; El Etreby LA; Abdel Hamid AT; Elmosalami D; El Hariri H; Said ZN
    Vaccine; 2016 Apr; 34(16):1904-8. PubMed ID: 26930367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes.
    del Canho R; Grosheide PM; Voogd M; Huisman WM; Heijtink RA; Schalm SW
    J Med Virol; 1993 Sep; 41(1):30-4. PubMed ID: 8228934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.
    Bryan JP; MacArthy P; Rudock A; Fogarty JP; Dowd H; Legters LJ; Perine PL
    Am J Infect Control; 1997 Jun; 25(3):215-22. PubMed ID: 9202817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two booster dose hepatitis B virus vaccination in patients with leukemia.
    Yetgin S; Tunç B; Koç A; Toksoy HB; Ceyhan M; Kanra G
    Leuk Res; 2001 Aug; 25(8):647-9. PubMed ID: 11397468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.
    Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W
    Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization.
    Chiaramonte M; Ngatchu T; Majori S; Baldo V; Moschen ME; Renzulli G; Trivello R
    Scand J Gastroenterol; 1995 Jun; 30(6):601-3. PubMed ID: 7569770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
    Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.